Catalyst Wire Dossier Catalyst Wire Dossier

Anrikefon Injection

· Tianjin Medical University Cancer Institute and Hospital
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anrikefon Injection, covering 2026-01-09 to 2026-01-09. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Anrikefon Injection for the Treatment of Postoperative Pain in Patients Undergoing Totally Laparoscopic Radical Distal Gastrectomy [Phase 2]

See pricing